BGI Genomics Co., Ltd.

SZSE:300676.SZ

46.6 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024202320222021202020192018201720162015201420132012
Operating Activities:
Net Income -912.10192.9809.4431,477.6992,102.052278.519407.844423.686350.017272.05558.53172.66885.354
Depreciation & Amortization 483.529436.836453.035370.601302.331241.076169.02112.97894.50488.54491.00241.00519.502
Deferred Income Tax 0010.365-34.519-85.20217.422-20.647-10.682-2.5629.17000
Stock Based Compensation 000095.9600000000
Change In Working Capital -188.554-504.614-1,485.895537.081956.345-397.283-609.832-315.358-173.156-24.719-173.359-189.986-39.324
Accounts Receivables -438.842736.488-1,059.597254.154-471.963-421.609-585.918-278.217-250.641-110.249-125.265-145.009-338.831
Inventory -34.2103.78246.255169.935-603.699-101.065-103.324-64.98837.807-24.34-19.673-36.902-9.377
Accounts Payables 0-1,344.884-482.918147.5112,117.209107.969102.47438.52945.574110.445000
Other Working Capital 284.489010.365-34.519-85.20217.422-506.508-250.37-210.963-0.379-153.686-153.084-29.947
Other Non Cash Items 712.849383.646326.58490.752231.206101.94347.6555.265-37.292-7.19815.66313.0156.957
Operating Cash Flow 95.723408.768136.3792,476.1323,602.693224.25514.687226.571234.074328.683-8.16436.70272.489
Investing Activities:
Investments In Property Plant And Equipment -529.481-1,236.385-1,266.62-383.52-301.153-626.439-678.126-291.33-246.007-177.261-556.254-284.877-61.889
Acquisitions Net 001.1455.9054.0391.3-31.8362.45540.262-27.601-14.351-31.9280
Purchases Of Investments -11,843.551-4,095.787-2,562.514-4,198-3,938.238-247.784-161.361-84.328-86.918-69.452-19.228-0.40
Sales Maturities Of Investments 12,058.0543,343.8143,239.3132,303.2044,431.5158.43281.10457.24376.40746.8240.4881.4230
Other Investing Activites 0.562237.6175.104-19.639-2.18721.8271,292.217-76.807294.36-1,741.85753.95218.56411.5
Investing Cash Flow -314.416-1,750.741-583.573-2,292.05193.976-842.665501.998-392.76778.104-1,969.347-535.393-297.218-50.39
Financing Activities:
Debt Repayment 155.066239.678-673.5-585.5961,263.4130-85-5.129-1.0496.7881.55-2.1
Common Stock Issued 082.85164.06226.105482.32-197.2160-14.1200000
Common Stock Repurchased 00-363.33-26.105-482.32-3.3750000000
Dividends Paid -50.363-416.735-143.47-144.87-40.01-40.01-200.321-108.53-82.932-0.77-0.298-0.145-0.628
Other Financing Activities -787.855-89.826-81.2321,844.084409.345388.017-280.112475.549-5.2111,651.838729.383222.994273.597
Financing Cash Flow -683.152-266.882-1,194.5371,037.3071,150.428348.007-488.162372.549-93.2721,650.789736.17224.398270.869
Other Information:
Effect Of Forex Changes On Cash 45.12132.822279.379-139.909-262.5155.21415.699-8.35113.133-1.9630.043-0.199-0.25
Net Change In Cash -856.724-1,576.033-1,362.3521,081.484,684.581-265.18944.222198.002232.0398.163192.657-36.318292.719
Cash At End Of Period 2,698.4173,555.1415,129.1926,491.5445,410.064725.484990.673946.45748.448516.41508.247315.591351.909